Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Parotid secretory protein
(
PSP
) and palate-lung-nasal epithelium clone (PLUNC) are novel secretory proteins that are expressed in the oral cavity and upper airways. Both proteins are related to bactericidal/permeability increasing protein (BPI). Cationic peptides derived from BPI exhibit anti-inflammatory activity. To test if
PSP
(
C20orf70
gene product) also contains anti-inflammatory peptides, we designed 3 cationic peptides based on the predicted structure of
PSP
and known active regions of BPI. Each peptide inhibited the lipopolysaccharide (LPS)-stimulated secretion of TNFalpha from RAW 264.7 macrophage cells. At 200 microg/mL, the peptide GK-7 exhibited inhibition similar to that achieved with 10 microg/mL of polymyxin B.
PSP
peptides directly inhibited the binding of LPS to LPS-binding protein. The cationic peptide
Substance P
had no inhibitory effect in these assays, confirming the specificity of the
PSP
peptides. These findings suggest that
PSP
peptides can serve as templates for the design of novel anti-inflammatory peptides.
...
PMID:Design and validation of anti-inflammatory peptides from human parotid secretory protein. 1566 32